Skip to main content

N Mori

First name:
N
Last name:
Mori
Takata, A. ., Miyake, N. ., Tsurusaki, Y. ., Fukai, R. ., Miyatake, S. ., Koshimizu, E. ., … Matsumoto, N. . (2018). Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. Cell Reports, 22(3), 734-747. https://doi.org/10.1016/j.celrep.2017.12.074 (Original work published 2018)
Fleck, D. ., Eliassen, J. ., Guerdjikova, A. ., Mori, N. ., Williams, S. ., Blom, T. ., … McElroy, S. . (2019). Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder. Psychiatry Research. Neuroimaging, 286, 53-59. https://doi.org/10.1016/j.pscychresns.2019.03.003 (Original work published 2019)
McElroy, S. ., Guerdjikova, A. ., Mori, N. ., & Romo-Nava, F. . (2019). Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa. CNS Drugs, 33(1), 31-46. https://doi.org/10.1007/s40263-018-0594-5
Guerdjikova, A. ., Mori, N. ., Casuto, L. ., & McElroy, S. . (2019). Update on Binge Eating Disorder. The Medical Clinics of North America, 103(4), 669-680. https://doi.org/10.1016/j.mcna.2019.02.003
Guerdjikova, A. ., Blom, T. ., Mori, N. ., Matthews, A. ., Cummings, T. ., Casuto, L. ., & McElroy, S. . (1969). Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review. Clinical Neuropharmacology, 42(6), 214-216. https://doi.org/10.1097/WNF.0000000000000367 (Original work published 1969)
Guerdjikova, A. ., Romo-Nava, F. ., Blom, T. ., Mori, N. ., & McElroy, S. . (2021). Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder. Contemporary Clinical Trials, 110, 106587. https://doi.org/10.1016/j.cct.2021.106587